{"matchedTerms": [], "ambiguousTerms": [{"searchTerm": "29", "geneName": "ABR", "geneLongName": "ACTIVE BCR-RELATED", "entrezId": 29, "geneCategories": [], "interactions": []}, {"searchTerm": "29", "geneName": "ABCA1", "geneLongName": "ATP BINDING CASSETTE SUBFAMILY A MEMBER 1", "entrezId": 19, "geneCategories": [{"id": "9bcd3de20cbc41da8d8ba4c693c93c8b", "name": "TRANSPORTER"}, {"id": "26f6a4ea7779433ea2cbf524683accf7", "name": "CELL SURFACE"}, {"id": "dd2a14c336214bd4a6581a99e5d9dbfd", "name": "EXTERNAL SIDE OF PLASMA MEMBRANE"}, {"id": "00f6836cd18c4d1ab6fa29d672375ae0", "name": "ABC TRANSPORTER"}, {"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}], "interactions": [{"interactionId": "84679ff3-fe7e-475b-8277-5a25d3b698f9", "interactionTypes": [], "drugName": "SIMVASTATIN", "drugConceptId": "chembl:CHEMBL1064", "sources": ["PharmGKB"], "pmids": [20031551], "score": 0.38}, {"interactionId": "1234a434-bd70-4093-9dc7-055baa3d6158", "interactionTypes": ["inhibitor"], "drugName": "PROBUCOL", "drugConceptId": "chembl:CHEMBL608", "sources": ["ChemblInteractions", "TTD"], "pmids": [19075491, 19458386, 15514211, 1868500, 20075420, 19427182], "score": 41.22}, {"interactionId": "988493d4-f2b7-4922-bf7f-24121bb35e28", "interactionTypes": [], "drugName": "FENOFIBRATE", "drugConceptId": "chembl:CHEMBL672", "sources": ["PharmGKB"], "pmids": [], "score": 0.36}, {"interactionId": "6edf8734-0627-4b8d-9065-8673fa054a50", "interactionTypes": [], "drugName": "CYCLOSPORINE", "drugConceptId": "chembl:CHEMBL160", "sources": ["NCI"], "pmids": [15084924], "score": 0.33}, {"interactionId": "8dc95ae1-84a3-4558-9656-88cc01f203ff", "interactionTypes": [], "drugName": "PRAVASTATIN", "drugConceptId": "chembl:CHEMBL1144", "sources": ["PharmGKB"], "pmids": [19673941, 20031551], "score": 0.88}, {"interactionId": "1ade10bb-17da-4653-a1c5-c3878080e77f", "interactionTypes": [], "drugName": "ATORVASTATIN", "drugConceptId": "chembl:CHEMBL1487", "sources": ["PharmGKB"], "pmids": [20031551], "score": 0.34}]}, {"searchTerm": "29", "geneName": "KIT", "geneLongName": "KIT PROTO-ONCOGENE RECEPTOR TYROSINE KINASE", "entrezId": 3815, "geneCategories": [{"id": "4c14ec3171544bd2b18b2f1a45e6c8f2", "name": "KINASE"}, {"id": "6c528ef943614261afc5e4f52a3c60ee", "name": "TYROSINE KINASE"}, {"id": "655bedfa9d71482796a5a34b87dfb297", "name": "DRUG RESISTANCE"}, {"id": "dd2a14c336214bd4a6581a99e5d9dbfd", "name": "EXTERNAL SIDE OF PLASMA MEMBRANE"}, {"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}, {"id": "0d157beb-fd17-404d-8755-3a81aa5ed704", "name": "CLINICALLY ACTIONABLE"}, {"id": "8f0fa3ca-6afd-45e3-9ef1-21241cd76aef", "name": "TRANSCRIPTION FACTOR"}], "interactions": [{"interactionId": "72566f10-7994-429b-a580-97ccc62f587b", "interactionTypes": [], "drugName": "GW843682X", "drugConceptId": "chembl:CHEMBL514499", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "e400a6bc-b661-4afe-a93e-dedaf4f9ad6c", "interactionTypes": [], "drugName": "CHEMBL578061", "drugConceptId": "chembl:CHEMBL578061", "sources": ["DTC"], "pmids": [], "score": 0.04}, {"interactionId": "22f37efe-dcc3-4c14-b3a7-743af781136e", "interactionTypes": ["inhibitor"], "drugName": "CM-082", "drugConceptId": "chembl:CHEMBL3545427", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.25}, {"interactionId": "96e054d3-c632-4716-a22e-52c4e8b265ad", "interactionTypes": [], "drugName": "SP-600125", "drugConceptId": "chembl:CHEMBL1725279", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "375a6436-f725-4e31-910d-19b959013c29", "interactionTypes": ["inhibitor"], "drugName": "CEDIRANIB", "drugConceptId": "chembl:CHEMBL491473", "sources": ["TALC", "ChemblInteractions"], "pmids": [], "score": 0.04}, {"interactionId": "8489cc39-2394-4afd-9046-b21093c4f2a1", "interactionTypes": ["inhibitor"], "drugName": "AXITINIB", "drugConceptId": "chembl:CHEMBL1289926", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "CancerCommons"], "pmids": [], "score": 0.34}, {"interactionId": "62ce49df-e119-4789-9944-3e8f385f2afc", "interactionTypes": ["inhibitor"], "drugName": "MOTESANIB", "drugConceptId": "chembl:CHEMBL572881", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "JAX-CKB", "ChemblInteractions"], "pmids": [20633291], "score": 0.76}, {"interactionId": "ed18a9b8-b47b-44dd-894f-fb556838194e", "interactionTypes": ["inhibitor"], "drugName": "FAMITINIB", "drugConceptId": "chembl:CHEMBL3545026", "sources": ["ChemblInteractions", "TTD"], "pmids": [], "score": 0.29}, {"interactionId": "a87d30e5-c626-4a75-b0af-9e90e6492e83", "interactionTypes": [], "drugName": "TRAMETINIB", "drugConceptId": "chembl:CHEMBL2103875", "sources": ["JAX-CKB"], "pmids": [28514312], "score": 0.05}, {"interactionId": "280a9981-e1cf-46d2-88b3-92846e50c976", "interactionTypes": ["inhibitor"], "drugName": "CABOZANTINIB", "drugConceptId": "chembl:CHEMBL2105717", "sources": ["MyCancerGenome", "JAX-CKB"], "pmids": [24205792, 25836719, 27777285], "score": 0.36}, {"interactionId": "3f485e9a-58f5-4732-895e-becd490725e5", "interactionTypes": [], "drugName": "PEMBROLIZUMAB", "drugConceptId": "chembl:CHEMBL3137343", "sources": ["JAX-CKB"], "pmids": [28514312], "score": 0.09}, {"interactionId": "cd85a572-4891-44f1-a93e-0715a337e71a", "interactionTypes": ["inhibitor"], "drugName": "ILORASERTIB", "drugConceptId": "chembl:CHEMBL1980297", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "5b844025-0340-4a92-ac8e-53c56f37cb42", "interactionTypes": ["inhibitor"], "drugName": "RG-1530", "drugConceptId": "chembl:CHEMBL1980391", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "0dc0585c-34bc-41f7-8a77-84e17e3fd574", "interactionTypes": [], "drugName": "MK-2206", "drugConceptId": "chembl:CHEMBL1079175", "sources": ["JAX-CKB"], "pmids": [27370604], "score": 0.12}, {"interactionId": "943e6984-ed89-4384-bbce-b5f57ee44cf0", "interactionTypes": ["inhibitor"], "drugName": "ENMD-2076", "drugConceptId": "chembl:CHEMBL482968", "sources": ["TdgClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.08}, {"interactionId": "e13ff4fc-da0d-41ed-843e-a3861f4b7dfc", "interactionTypes": ["inhibitor"], "drugName": "XL-999", "drugConceptId": "chembl:CHEMBL3545285", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.09}, {"interactionId": "b05fd0bd-9544-40d3-83ae-110135e7c735", "interactionTypes": ["inhibitor"], "drugName": "PAZOPANIB HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL1201733", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.09}, {"interactionId": "557789b7-0ebd-46b8-87d8-7fad2866d2ac", "interactionTypes": ["inhibitor"], "drugName": "CENISERTIB", "drugConceptId": "chembl:CHEMBL1967878", "sources": ["TALC", "DTC", "MyCancerGenome"], "pmids": [], "score": 0.03}, {"interactionId": "969d38bc-4f43-4a4e-82cf-0dbb277db3e4", "interactionTypes": ["inhibitor"], "drugName": "QUIZARTINIB", "drugConceptId": "chembl:CHEMBL576982", "sources": ["JAX-CKB", "ChemblInteractions", "DoCM"], "pmids": [23497317, 21689725, 24045550, 19164557, 15972446, 16384925, 18024392, 18986703, 22504184, 16912224, 23714533, 25157968, 17259998, 23582185, 16731599], "score": 2.03}, {"interactionId": "7a482c73-6b6d-4e54-a062-3cc0eb084ba5", "interactionTypes": ["inhibitor"], "drugName": "SUNITINIB MALATE", "drugConceptId": "chembl:CHEMBL1567", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.11}, {"interactionId": "22c9ae82-84a7-4a15-a977-975c9c0f2b3a", "interactionTypes": ["inhibitor"], "drugName": "AST-487", "drugConceptId": "chembl:CHEMBL574738", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "9d349a3d-3a12-4d52-9f1d-eb83c3adb662", "interactionTypes": [], "drugName": "AMG-191", "drugConceptId": "chembl:CHEMBL2109325", "sources": ["TTD"], "pmids": [], "score": 1.01}, {"interactionId": "2cc3c230-96d1-4046-816f-2662837d6c03", "interactionTypes": ["inhibitor"], "drugName": "VATALANIB", "drugConceptId": "chembl:CHEMBL101253", "sources": ["TALC", "DTC", "TdgClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.31}, {"interactionId": "dab51b54-c3d9-4ddc-85c0-8ba691dad6d9", "interactionTypes": ["inhibitor"], "drugName": "TELATINIB", "drugConceptId": "chembl:CHEMBL2079588", "sources": ["TALC", "MyCancerGenome", "ChemblInteractions"], "pmids": [], "score": 0.51}, {"interactionId": "a4e4f87d-bd5f-48b4-bf2a-819bdadc7226", "interactionTypes": [], "drugName": "BEVACIZUMAB", "drugConceptId": "chembl:CHEMBL1201583", "sources": ["JAX-CKB"], "pmids": [25363205], "score": 0.07}, {"interactionId": "4ccd224b-2a4b-493e-9cdf-22a56b65c3e7", "interactionTypes": [], "drugName": "SNS-314", "drugConceptId": "chembl:CHEMBL482767", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "d3f41d5f-3a39-45c2-9d5b-e5d91658f311", "interactionTypes": ["inhibitor"], "drugName": "AVAPRITINIB", "drugConceptId": "chembl:CHEMBL4204794", "sources": ["JAX-CKB", "TTD", "OncoKB"], "pmids": [31117741], "score": 2.03}, {"interactionId": "a1b233db-2f8c-48ad-9d63-9f842d125846", "interactionTypes": ["inhibitor"], "drugName": "SEMAXANIB", "drugConceptId": "chembl:CHEMBL276711", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.07}, {"interactionId": "22caabf1-e2b6-440e-959a-f5f0be29ff92", "interactionTypes": ["inhibitor"], "drugName": "OSI-930", "drugConceptId": "chembl:CHEMBL1614710", "sources": ["ChemblInteractions", "TTD"], "pmids": [], "score": 0.41}, {"interactionId": "a0103941-136a-442f-9290-ecdaea1b47d9", "interactionTypes": ["antagonist", "inhibitor"], "drugName": "NILOTINIB", "drugConceptId": "chembl:CHEMBL255863", "sources": ["JAX-CKB", "COSMIC", "CIViC", "CancerCommons", "MyCancerGenomeClinicalTrial"], "pmids": [28720666, 28843487, 20442311, 25594040, 26424760, 21456006, 17372901, 25209843, 22119758, 28327988, 22068222, 25695690, 19671763, 17699867, 23582185], "score": 1.84}, {"interactionId": "7c000fc4-21fc-408a-bdd7-c2c75b2ca0cf", "interactionTypes": ["inhibitor"], "drugName": "XL-820", "drugConceptId": "chembl:CHEMBL3545402", "sources": ["ChemblInteractions", "TTD"], "pmids": [], "score": 0.34}, {"interactionId": "3e11b969-9395-4850-a60a-72517731da3f", "interactionTypes": ["inhibitor"], "drugName": "AMUVATINIB", "drugConceptId": "chembl:CHEMBL2103851", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions"], "pmids": [17325667], "score": 0.72}, {"interactionId": "36592173-3f92-45d1-8ac2-3df37baf801f", "interactionTypes": ["antagonist", "inhibitor"], "drugName": "MIDOSTAURIN", "drugConceptId": "chembl:CHEMBL608533", "sources": ["MyCancerGenome", "JAX-CKB", "ChemblInteractions", "CIViC", "PharmGKB", "FDA"], "pmids": [25209843, 16969355, 27355533], "score": 0.36}, {"interactionId": "55ee1c6a-fba9-4e3a-b8fd-d84a0f2426a4", "interactionTypes": [], "drugName": "ROMIPLOSTIM", "drugConceptId": "chembl:CHEMBL1201832", "sources": ["TTD"], "pmids": [], "score": 0.13}, {"interactionId": "2e9e4baf-4876-4661-abd9-0bdd3d9d4663", "interactionTypes": ["inhibitor"], "drugName": "FORETINIB", "drugConceptId": "chembl:CHEMBL1230609", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.08}, {"interactionId": "bb0ec076-c1e2-40a1-a652-cbd2de8a0ccd", "interactionTypes": ["inhibitor"], "drugName": "IMATINIB MESYLATE", "drugConceptId": "chembl:CHEMBL1642", "sources": ["ChemblInteractions", "TTD"], "pmids": [], "score": 0.2}, {"interactionId": "836dc6f2-545b-49c4-a705-8b7152f438f7", "interactionTypes": ["inhibitor"], "drugName": "SORAFENIB TOSYLATE", "drugConceptId": "chembl:CHEMBL1200485", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.06}, {"interactionId": "423f1a1a-6286-454e-9bfc-65566234d0ae", "interactionTypes": ["inhibitor"], "drugName": "SU-014813", "drugConceptId": "chembl:CHEMBL1721885", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.14}, {"interactionId": "4b8420f0-a953-44e7-99a5-e64f018d777f", "interactionTypes": [], "drugName": "ENTRECTINIB", "drugConceptId": "chembl:CHEMBL1983268", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "65dd33d2-807d-45c6-9099-52d9cd60ef0b", "interactionTypes": ["inhibitor"], "drugName": "LENVATINIB", "drugConceptId": "chembl:CHEMBL1289601", "sources": ["TdgClinicalTrial"], "pmids": [17943726], "score": 0.17}, {"interactionId": "19db79cb-ac13-41a1-8393-ba5dc9141a59", "interactionTypes": ["inhibitor"], "drugName": "TANDUTINIB", "drugConceptId": "chembl:CHEMBL124660", "sources": ["DTC", "MyCancerGenome", "ChemblInteractions"], "pmids": [], "score": 0.3}, {"interactionId": "c2c9a912-c8ca-4f3d-9721-e6423c73f8f6", "interactionTypes": [], "drugName": "BARASERTIB", "drugConceptId": "chembl:CHEMBL415049", "sources": ["DTC"], "pmids": [], "score": 0.11}, {"interactionId": "6006586d-977b-41aa-b8ee-b90e287aec0b", "interactionTypes": [], "drugName": "INFIGRATINIB", "drugConceptId": "chembl:CHEMBL1852688", "sources": ["JAX-CKB"], "pmids": [25673643], "score": 0.09}, {"interactionId": "4532073f-4adc-4e06-a02f-93af61143c4b", "interactionTypes": [], "drugName": "JNJ-7706621", "drugConceptId": "chembl:CHEMBL191003", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "0e3a1a64-a53e-4bbf-b245-d8b801d5081c", "interactionTypes": ["inhibitor"], "drugName": "PEXIDARTINIB", "drugConceptId": "chembl:CHEMBL3813873", "sources": ["MyCancerGenome", "JAX-CKB", "ChemblInteractions", "CancerCommons", "TTD"], "pmids": [28716061, 24583793], "score": 1.18}, {"interactionId": "1e3c3df3-f1c0-4827-9c61-e750c88677b0", "interactionTypes": ["inhibitor"], "drugName": "PONATINIB", "drugConceptId": "chembl:CHEMBL1171837", "sources": ["DTC", "JAX-CKB", "CIViC", "TTD"], "pmids": [24552773, 10517, 21482694, 20513156, 22301675, 25239608, 10535, 23539538, 2015], "score": 0.6}, {"interactionId": "f04ff45e-e598-414b-a85d-2373014bd2d8", "interactionTypes": ["inhibitor"], "drugName": "PAZOPANIB", "drugConceptId": "chembl:CHEMBL477772", "sources": ["TALC", "MyCancerGenome", "MyCancerGenomeClinicalTrial"], "pmids": [17288876], "score": 0.1}, {"interactionId": "3f7943b9-3bca-4031-afe6-779065cfcda7", "interactionTypes": ["inhibitor"], "drugName": "RIPRETINIB", "drugConceptId": "chembl:CHEMBL4216467", "sources": ["JAX-CKB", "TTD"], "pmids": [32273716, 31755321], "score": 2.03}, {"interactionId": "8b037e3e-f17d-4c0e-a80e-b9d934aaae08", "interactionTypes": ["inhibitor"], "drugName": "REGORAFENIB", "drugConceptId": "chembl:CHEMBL1946170", "sources": ["TALC", "MyCancerGenome", "JAX-CKB", "ChemblInteractions", "CIViC", "MyCancerGenomeClinicalTrial", "TTD", "OncoKB"], "pmids": [21170960, 27371698, 25239608], "score": 0.4}, {"interactionId": "f0c80ae6-df32-4e30-8ef9-3c16a09651c6", "interactionTypes": ["antagonist", "inhibitor", "multitarget"], "drugName": "IMATINIB", "drugConceptId": "chembl:CHEMBL941", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "JAX-CKB", "TEND", "DoCM", "COSMIC", "CIViC", "PharmGKB", "TTD", "FDA", "OncoKB"], "pmids": [18795925, 17458563, 15790786, 9438854, 21159146, 21689725, 20088873, 26316776, 24045550, 27370604, 18936790, 24317392, 25673643, 26687836, 7530509, 15236194, 19164557, 22114577, 15201427, 15972446, 16384925, 18024392, 27980106, 12481435, 15685537, 25015329, 28611108, 19861435, 11276010, 25594040, 21969494, 16638875, 28196207, 18986703, 21953054, 16143141, 21690468, 24419427, 23375402, 18980976, 22357254, 17372901, 22504184, 25003536, 18955458, 23567324, 24687822, 22261812, 16908931, 16624552, 19175693, 16912224, 25239608, 15930355, 18421059, 19812602, 18955451, 23775962, 23714533, 19671763, 25157968, 20372153, 16046538, 17699867, 22932406, 14645423, 17363509, 11526490, 17259998, 12374669, 21642685, 18751412, 16954519, 16865565, 16015387, 16462496, 16434489, 16751810, 16087693, 23582185, 27777285, 17559139, 22355224, 17369583, 28334365, 16731599], "score": 1.58}, {"interactionId": "388c5011-6629-4184-91ac-818b4201101d", "interactionTypes": ["inhibitor"], "drugName": "SUNITINIB", "drugConceptId": "chembl:CHEMBL535", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "JAX-CKB", "TEND", "DoCM", "COSMIC", "CIViC", "MyCancerGenomeClinicalTrial", "PharmGKB", "OncoKB"], "pmids": [19164557, 17545799, 19248971, 19861435, 25594040, 21969494, 17367763, 16638875, 21690468, 23375402, 22357254, 18955458, 22261812, 25239608, 14753710, 22439647, 11752352, 18421059, 21642685, 12748309, 23582185, 26772734, 12873999], "score": 0.88}, {"interactionId": "b5c2190f-0c74-4e28-96f9-e01740b5ca8f", "interactionTypes": ["antagonist", "inhibitor"], "drugName": "SORAFENIB", "drugConceptId": "chembl:CHEMBL1336", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "JAX-CKB", "TEND", "DoCM", "CIViC", "PharmGKB", "TTD", "OncoKB"], "pmids": [19139124, 18936790, 24317392, 17229632, 17102120, 22665524, 22357254, 17545544, 17178882, 28362716, 19671763, 20372153, 17699867, 19461405, 25363205, 17272980, 20970876], "score": 0.34}, {"interactionId": "278c0ec8-6ac7-45c4-881c-2965109cf333", "interactionTypes": [], "drugName": "CHEMBL541400", "drugConceptId": "chembl:CHEMBL541400", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "df709208-d519-47d2-9269-f945272c3d21", "interactionTypes": [], "drugName": "PD-0325901", "drugConceptId": "chembl:CHEMBL507361", "sources": ["JAX-CKB"], "pmids": [26936919], "score": 0.18}, {"interactionId": "a521712d-d383-47c2-b652-573eaa27f071", "interactionTypes": [], "drugName": "CYTARABINE", "drugConceptId": "chembl:CHEMBL803", "sources": ["JAX-CKB"], "pmids": [18986703], "score": 0.05}, {"interactionId": "99036f25-f2fe-47b2-a548-bb9541268b64", "interactionTypes": ["inhibitor"], "drugName": "ANLOTINIB", "drugConceptId": "chembl:CHEMBL3545021", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.2}, {"interactionId": "d40419fe-2908-4e55-bbd0-32bfbf97348d", "interactionTypes": ["antagonist", "inhibitor"], "drugName": "DASATINIB", "drugConceptId": "chembl:CHEMBL1421", "sources": ["TALC", "TdgClinicalTrial", "JAX-CKB", "ChemblInteractions", "TEND", "DoCM", "CIViC", "CancerCommons", "MyCancerGenomeClinicalTrial"], "pmids": [21689725, 24045550, 32092139, 19164557, 15972446, 16384925, 18024392, 15685537, 17351742, 23149070, 25594040, 18986703, 21953054, 17372901, 22504184, 16912224, 18559612, 23714533, 19671763, 25157968, 17699867, 22932406, 17259998, 21642685, 16434489, 16397263, 23582185, 16731599], "score": 0.54}, {"interactionId": "79f8b856-46e1-42d7-aab3-7c5a87994a83", "interactionTypes": [], "drugName": "CYC-116", "drugConceptId": "chembl:CHEMBL482967", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "4fa92064-a703-4630-863a-a838051039fc", "interactionTypes": ["inhibitor"], "drugName": "DOVITINIB", "drugConceptId": "chembl:CHEMBL522892", "sources": ["DTC", "ClearityFoundationClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.03}, {"interactionId": "e4cce546-15b4-4d66-91e3-4513908abb70", "interactionTypes": ["inhibitor"], "drugName": "LINIFANIB", "drugConceptId": "chembl:CHEMBL223360", "sources": ["TdgClinicalTrial"], "pmids": [], "score": 0.01}, {"interactionId": "962ea1fd-fa2f-4fec-8944-2c82f70cf631", "interactionTypes": ["inhibitor"], "drugName": "MASITINIB", "drugConceptId": "chembl:CHEMBL1908391", "sources": ["MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions", "CancerCommons", "MyCancerGenomeClinicalTrial"], "pmids": [], "score": 0.36}]}], "unmatchedTerms": []}